The significance of diminished sTWEAK and P-selectin content in platelets of patients with pulmonary arterial hypertension.

Cytokine 2018 07 2;107:52-58. Epub 2017 Dec 2.

Department of Cardiology, Medical University of Bialystok, Sklodowskiej 24a, 15-276 Bialystok, Poland; Department of Population Medicine and Civilization Diseases Prevention, Medical University of Bialystok, Sklodowskiej 24a, 15-276 Bialystok, Poland. Electronic address:

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by proliferative changes in pulmonary arteries. There is growing evidence suggesting that soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and P-selectin could be involved in PAH development and progression. Here we investigate whether circulating platelets may be a source of sTWEAK and contribute to diminished availability of sTWEAK and P-selectin in PAH patients. We have prospectively enrolled two independent study groups of stable patients with confirmed PAH and age matched controls: derivation (10 PAH; 15 controls) and validation (20 PAH; 12 controls). P-selectin and sTWEAK concentrations were measured in platelet-poor plasma and platelet lysate. To avoid procedural bias, in each group we employed different protocols for platelet isolation. Consistently, both in derivation and validation groups PAH patients presented significantly lower sTWEAK content in platelets than control group with no significant differences in plasma levels. Similarly, patients presented comparable to controls plasma P-selectin concentrations and lower concentration in platelet lysate. Kaplan-Meier analysis revealed that patients with low platelet sTWEAK/total protein concentration ratio had more frequently detoriation of PAH in the follow-up (16.51 ± 3.32 months), log-rank test, p = .03. Patients diagnosed with pulmonary arterial hypertension present diminished sTWEAK and P-selectin storage capacity in platelets. Thrombocytes appear to be a major source of sTWEAK that could be released upon local injury and its decreased availability could have an impact on pathophysiology and prognosis in PAH.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cyto.2017.11.014DOI Listing
July 2018
12 Reads

Publication Analysis

Top Keywords

stweak p-selectin
16
arterial hypertension
12
pulmonary arterial
12
pah
9
pah patients
8
source stweak
8
platelet lysate
8
content platelets
8
pah controls
8
stweak
8
patients presented
8
diminished stweak
8
patients
7
p-selectin
6
controls
4
p-selectin stweak
4
matched controls
4
age matched
4
pah age
4
kaplan-meier analysis
4

Similar Publications